Responses
Poster Group IB – Monday, September 26, 2005
000197 THE ANTI-IDIOTYPIC MONOCLONAL ANTIBODY ACA125 IN PATIENTS WITH RECURRENT EPITHELIAL OVARIAN, FALLOPIAN TUBE OR PERITONEAL CANCER. A PHASE II TRIAL OF THE AGO-OVAR
Compose a Response to This Article
Other responses
No responses have been published for this article.